Prognostic Factors for Bladder Cancer Patients in Malaysia: A Population-Based Study

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2022 Mar 10

PMID 35270721

Authors

Mohd Nasrullah Nik Ab Kadir

Suhaily Mohd Hairon

Najib Majdi Yaacob

Azizah Ab Manan

Nabihah Ali

Affiliations

Soon will be listed here.

Abstract

Background: Malaysia has the third highest crude mortality rates of bladder cancer within Southeast Asia. We aimed to identify the prognostic factors for bladder cancer patients in Malaysia.

Methods: A retrospective population-based study was conducted among patients diagnosed between 2007 and 2011. Death date until 31 December 2016 was updated. Cox proportional hazard regression analysis was performed to examine clinical variables as prognostic factors of death.

Results: Identified prognostic factors of 1828 analyzed patients were age groups, ethnicity, morphology, stage, and surgery. As compared to patients aged 15-44, the adjusted Hazard Ratio for those aged 45-54, 55-64, 65-74, and ≥75 were 1.59, 1.87, 2.46, and 3.47, respectively. Malay and other ethnic groups had 1.22- and 1.40-times the risk of death compared to Chinese. Patients with squamous cell carcinoma were at 1.47-times the hazard of death compared to urothelial carcinoma patients. Stages II, III and IV patients had 2.20-, 2.98-, and 4.12-times the risk of death as compared to stage I. Patients who did not receive surgery were at 50% increased hazard of death.

Conclusion: Early detection and/or surgery, especially for those more than 75 years old, Malay, and squamous cell carcinoma could potentially improve survival. The findings could inform national cancer control programs.

References

Patel M, Bang A, Gillett D, Cheluvappa R, Smith D . Poor survival of females with bladder cancer is limited to those aged 70 years or over: a population-wide linkage study, New South Wales, Australia. Cancer Med. 2015; 4(8):1145-52. PMC: 4559025. DOI: 10.1002/cam4.452. View

Zaitsu M, Toyokawa S, Tonooka A, Nakamura F, Takeuchi T, Homma Y . Sex differences in bladder cancer pathology and survival: analysis of a population-based cancer registry. Cancer Med. 2014; 4(3):363-70. PMC: 4380962. DOI: 10.1002/cam4.379. View

Smith A, Deal A, Woods M, Wallen E, Pruthi R, Chen R . Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base. BJU Int. 2013; 114(5):719-26. DOI: 10.1111/bju.12601. View

Feng H, Zhang W, Li J, Lu X . Different patterns in the prognostic value of age for bladder cancer-specific survival depending on tumor stages. Am J Cancer Res. 2015; 5(6):2090-7. PMC: 4529628. View

Cahn D, Handorf E, Ghiraldi E, Ristau B, Geynisman D, Churilla T . Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer. Cancer. 2017; 123(22):4337-4345. DOI: 10.1002/cncr.30900. View

Nik Ab Kadir M, Mohd Hairon S, Yaacob N, Ab Manan A, Ali N . Survival and Characteristics of Bladder Cancer: Analysis of the Malaysian National Cancer Registry. Int J Environ Res Public Health. 2021; 18(10). PMC: 8156894. DOI: 10.3390/ijerph18105237. View

Uhlig A, Seif Amir Hosseini A, Simon J, Lotz J, Trojan L, Schmid M . Gender Specific Differences in Disease-Free, Cancer Specific and Overall Survival after Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis. J Urol. 2018; 200(1):48-60. DOI: 10.1016/j.juro.2017.11.150. View

Royce T, Lin C, Gray P, Shipley W, Jemal A, Efstathiou J . Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data Base. Urol Oncol. 2017; 36(2):78.e1-78.e12. DOI: 10.1016/j.urolonc.2017.10.013. View

Zakaria A, Santos F, Kassouf W, Tanguay S, Aprikian A . Survival after Radical Cystectomy for Bladder Cancer in Relation to Prior Non-Muscle Invasive Disease in Quebec. Urol Int. 2016; 97(1):49-53. DOI: 10.1159/000444093. View

10.

Rose T, Deal A, Nielsen M, Smith A, Milowsky M . Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer. Cancer. 2016; 122(13):2012-20. PMC: 4911298. DOI: 10.1002/cncr.30029. View

11.

Haque W, Verma V, Butler E, Teh B . National Practice Patterns and Outcomes for T4b Urothelial Cancer of the Bladder. Clin Genitourin Cancer. 2017; . DOI: 10.1016/j.clgc.2017.08.013. View

12.

Kozak K, Hamidi M, Manning M, Moody J . Bladder preservation for localized muscle-invasive bladder cancer: the survival impact of local utilization rates of definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2012; 83(2):e197-204. PMC: 3351503. DOI: 10.1016/j.ijrobp.2011.12.038. View

13.

Haque W, Verma V, Butler E, Teh B . Radical Cystectomy Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics. Anticancer Res. 2017; 37(10):5603-5608. DOI: 10.21873/anticanres.11994. View

14.

Klapheke A, Yap S, Pan K, Cress R . Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer. Urol Oncol. 2018; 36(6):308.e19-308.e25. PMC: 5960436. DOI: 10.1016/j.urolonc.2018.03.008. View

15.

Keck B, Ott O, Haberle L, Kunath F, Weiss C, Rodel C . Female sex is an independent risk factor for reduced overall survival in bladder cancer patients treated by transurethral resection and radio- or radiochemotherapy. World J Urol. 2012; 31(5):1023-8. DOI: 10.1007/s00345-012-0971-5. View

16.

Yafi F, Aprikian A, Chin J, Fradet Y, Izawa J, Estey E . Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int. 2010; 108(4):539-45. DOI: 10.1111/j.1464-410X.2010.09912.x. View

17.

Muhamad N, Kamaluddin M, Adon M, Noh M, Bakhtiar M, Ibrahim Tamim N . Survival rates of cervical cancer patients in Malaysia. Asian Pac J Cancer Prev. 2015; 16(7):3067-72. DOI: 10.7314/apjcp.2015.16.7.3067. View

18.

Larre S, Catto J, Cookson M, Messing E, Shariat S, Soloway M . Screening for bladder cancer: rationale, limitations, whom to target, and perspectives. Eur Urol. 2013; 63(6):1049-58. DOI: 10.1016/j.eururo.2012.12.062. View

19.

Nordin N, Yaacob N, Abdullah N, Mohd Hairon S . Survival Time and Prognostic Factors for Breast Cancer among Women in North-East Peninsular Malaysia. Asian Pac J Cancer Prev. 2018; 19(2):497-502. PMC: 5980940. DOI: 10.22034/APJCP.2018.19.2.497. View

20.

Lara J, Brunson A, Keegan T, Malogolowkin M, Pan C, Yap S . Determinants of Survival for Adolescents and Young Adults with Urothelial Bladder Cancer: Results from the California Cancer Registry. J Urol. 2016; 196(5):1378-1382. PMC: 5319865. DOI: 10.1016/j.juro.2016.05.082. View